Indogulf Cropsciences Q4 FY26: Revenue Up 19% to ₹1,506 Cr, PAT Rises 19% to ₹116 Cr
Indogulf Cropsciences reported Q4 FY26 revenue of ₹1,506 crore (up 19% YoY) and PAT of ₹116 crore (up 19% YoY). For FY26, revenue grew 19% to ₹7,046 crore, with PAT up 27% to ₹400 crore. The company is shifting towards an integrated agri-solutions platform focusing on biologicals and farmer engagement.
The announcement details strong financial results and outlines a strategic shift towards an integrated agri-solutions platform, which is likely to have a substantial impact on the company's future growth and market position.
The company reported significant year-on-year growth in revenue and profit for both the quarter and the full fiscal year, indicating a positive financial performance.
Indogulf Cropsciences Limited has announced its financial results for the fourth quarter and full fiscal year ended March 31, 2026. The company reported a revenue of ₹1,506 crore for Q4 FY26, marking a 19% year-on-year increase. Profit After Tax (PAT) for the quarter stood at ₹116 crore, also up 19% compared to the same period last year.
For the full fiscal year 2025-26, Indogulf Cropsciences recorded a revenue of ₹7,046 crore, representing a 19% year-on-year growth. The company's PAT for FY26 surged by 27% to ₹400 crore. EBITDA for the full year increased by 15% to ₹740 crore.
The company's strategy is focused on evolving from a product-centric approach to an integrated agri-solutions platform. Key initiatives include expanding its biologicals and sustainable product portfolio, increasing the contribution of high-margin products, deepening farmer engagement through an advisory-led model, accelerating global expansion, strengthening operational excellence, and driving innovation. The company highlighted its diversified revenue streams, with B2C contributing 50%, B2B 38%, and Exports 11% of the revenue mix for FY26. Indogulf Cropsciences also presented its manufacturing strengths, backward integration, and expansive distribution network across India and 34+ countries.
What to do with a filing like this
Indogulf Cropsciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indogulf Cropsciences Limited. Read the original for the full detail.